Xwell (XWEL) EBT Margin (2010 - 2026)
Xwell (XWEL) posted EBT Margin of 165.89% for Q1 2026, down 28.14% sequentially from 129.47% in Q4 2025, and down 10057.0% YoY from N/an in Q1 2025.
Xwell (XWEL) EBT Margin (2010 - 2026) Analysis & Trends
Xwell has reported EBT Margin for 17 years, with the latest figure at 165.89% in Q1 2026.
- Quarterly EBT Margin fell 10057.0% year-over-year to 165.89% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 78.06% (down 2006.0% YoY) and the FY2025 annual result came in at 55.04%, down 654.0% from the prior year.
- EBT Margin fell to 165.89% in Q1 2026 per XWEL's latest filing, from 129.47% in the prior quarter.
- Over five years, EBT Margin peaked at 2.85% in Q3 2025 and troughed at 188.03% in Q4 2022.
- A 5-year average of 76.25% and a median of 66.12% in 2023 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2022 and 2023: EBT Margin slumped 19160 bps in 2022, then soared 12190 bps in 2023.
- Over 5 years, EBT Margin stood at 188.03% in 2022, then jumped by 65 bps to 66.12% in 2023, then sank by 54 bps to 101.61% in 2024, then retreated by 27 bps to 129.47% in 2025, then retreated by 28 bps to 165.89% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 165.89%, 129.47%, and 2.85% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 16.04% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 17.21% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 34.29% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 22.23% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 6.89% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -12.17% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 22.43% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 28.17% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 13.54% |
| 10 | Xwell | 7.47 Mn | -9.34 Mn | 2.35 Mn | -165.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -165.89% |
| Dec 31, 2025 | -129.47% |
| Sep 30, 2025 | -2.85% |
| Jun 30, 2025 | -26.25% |
| Mar 31, 2025 | -65.33% |
| Dec 31, 2024 | -101.61% |
| Sep 30, 2024 | -55.87% |
| Jun 30, 2024 | -19.30% |
| Mar 31, 2024 | -27.02% |
| Dec 31, 2023 | -66.12% |
| Sep 30, 2023 | -155.21% |
| Jun 30, 2023 | -69.47% |
| Mar 31, 2023 | -82.53% |
| Dec 31, 2022 | -188.03% |
| Sep 30, 2022 | -71.50% |
| Jun 30, 2022 | -58.28% |
| Mar 31, 2022 | -11.49% |
| Dec 31, 2021 | 3.58% |
| Sep 30, 2021 | 24.96% |
| Jun 30, 2021 | -52.12% |